Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Relapsed Ovarian Cancers Patients × olaparib × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 79 Fallopian Tube Neoplasms 21 Endometrial Neoplasms 17 Breast Neoplasms 16 Carcinoma, Ovarian Epithelial 10 Prostatic Neoplasms 7 Pancreatic Neoplasms 6 Neoplasms 6 Triple Negative Breast Neoplasms 4 Recurrence 4 Fanconi Anemia, Complementation Group D1 4 Uterine Cervical Neoplasms 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Peritoneal Neoplasms 2 Ovarian Diseases 2 Neoplasm Metastasis 2 Carcinosarcoma 2 Urogenital Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Relapsed Ovarian Cancers Patients 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Platinum-sensitive Ovarian Cancer 1 Platinum-Refractory Fallopian Tube Carcinoma 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 PSR Ovarian Cancer With a BRCA Mutation 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04152941 2023-09-06

RETROLA

ARCAGY/ GINECO GROUP

Relapsed Ovarian Cancers Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡